Capsida Clinical Trial Information

There has been much interest and excitement around the advancing development of a new gene therapy designed for STXBP1-related disorders by Capsida. As you can imagine, there has been a lot of requests for more information from our community as Capsida could start enrolling for a clinical trial in the second half of this year.

Our Scientific Director, James Goss, has outlined the most current info along with some frequently asked questions in this page here.